Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus

Endocrine

Volumn 41, Issue 3, 2012, Pages 424-429

  Aslan, Mehmet ^a   Celik, Onder ^a   Celik, Nilufer ^b   Turkcuoglu, Ilgin ^a   Yilmaz, Ercan ^a   Karaer, Abdullah ^a   Simsek, Yavuz ^a   Celik, Ebru ^a   Aydin, Suleyman ^c  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MALATYA STATE HOSPITAL   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

Author keywords

Apelin 36; Gestational diabetes mellitus; Insulin; Nesfatin 1

Indexed keywords

ADIPOCYTOKINE; APELIN 36; NESFATIN 1; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MATERNAL AGE; MATERNAL SERUM; METABOLIC PARAMETERS; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 84862677281     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9577-8     Document Type: Article

References (29)

1. B.E. Metzger, D.R. Coustan, Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. The Organizing Committee. Diabet. Care 21(Suppl 2), B161-B167 (1998) (Pubitemid 28357050)
2. American Diabetes Association, Gestational diabetes mellitus. Diabet. Care 26(Suppl 1), S103-S105 (2003)
3. D.R. Coustan, Making the diagnosis of gestational diabetes mellitus. Clin. Obstet. Gynecol. 43(1), 99-105 (2000) (Pubitemid 30414152)
4. B. Masri, N. Morin, L. Pedebernade, B. Knibiehler, Y. Audigier, The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments. J. Biol. Chem. 281(27), 18317-18326 (2006). doi:10.1074/jbc.M600606200 (Pubitemid 44035488)
5. K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, M.X. Zou, Y. Kawamata, S. Fukusumi, S. Hinuma, C. Kitada, T. Kurokawa, H. Onda, M. Fujino, Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251(2), 471-476 (1998). doi:10.1006/bbrc.1998.9489 (Pubitemid 28505047)
6. Y. Kawamata, Y. Habata, S. Fukusumi, M. Hosoya, R. Fujii, S. Hinuma, N. Nishizawa, C. Kitada, H. Onda, O. Nishimura, M. Fujino, Molecular properties of apelin: tissue distribution and receptor binding. Biochim. Biophys. Acta 1538(2-3), 162-171 (2001) (Pubitemid 32402239)
7. A.M. O'Carroll, T.L. Selby, M. Palkovits, S.J. Lolait, Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim. Biophys. Acta 1492(1), 72-80 (2000). doi:10.1016/S0167-4781(00)00072-5 (Pubitemid 30349182)
8. A.S. Hekmat, H. Najafipour, A.A. Nekooian, S. Esmaeli-Mahani, K. Javanmardi, Cardiovascular responses to apelin in two-kidneyone- clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys. Regul. Pept. 172(1-3), 62-68 (2011). doi:10.1016/j.regpep.2011.08.010
9. L. Li, G. Yang, Q. Li, Y. Tang, M. Yang, H. Yang, K. Li, Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp. Clin. Endocrinol. Diabet. 114(10), 544-548 (2006). doi:10.1055/s-2006-948309 (Pubitemid 46087259)
10. J. Boucher, B. Masri, D. Daviaud, S. Gesta, C. Guigne, A. Mazzucotelli, I. Castan-Laurell, I. Tack, B. Knibiehler, C. Carpene, Y. Audigier, J.S. Saulnier-Blache, P. Valet, Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146(4), 1764-1771 (2005). doi:10.1210/en.2004-1427 (Pubitemid 40396885)
11. F. Soriguer, L. Garrido-Sanchez, S. Garcia-Serrano, J.M. Garcia- Almeida, J. Garcia-Arnes, F.J. Tinahones, E. Garcia-Fuentes, Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes. Surg. 19(11), 1574-1580 (2009). doi: 10.1007/s11695-009-9955-y
12. I.S. Oh, H. Shimizu, T. Satoh, S. Okada, S. Adachi, K. Inoue, H. Eguchi, M. Yamamoto, T. Imaki, K. Hashimoto, T. Tsuchiya, T. Monden, K. Horiguchi, M. Yamada, M. Mori, Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443(7112), 709-712 (2006). doi:10.1038/nature05162 (Pubitemid 44564715)
13. K.S. Foo, H. Brismar, C. Broberger, Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 156(3), 563-579 (2008). doi:10.1016/j.neuroscience.2008.07.054
14. A. Stengel, M. Goebel, Y. Tache, Nesfatin-1: a novel inhibitory regulator of food intake and body weight. Obes. Rev. 12(4), 261-271 (2011). doi:10.1111/j.1467-789X.2010.00770.x
15. Q.C. Li, H.Y. Wang, X. Chen, H.Z. Guan, Z.Y. Jiang, Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul. Pept. 159(1-3), 72-77 (2010). doi:10.1016/j.regpep.2009.11.003
16. I. Castan-Laurell, C. Dray, C. Attane, T. Duparc, C. Knauf, P. Valet, Apelin, diabetes, and obesity. Endocrine 40(1), 1-9 (2011). doi:10.1007/s12020- 011-9507-9
17. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists No. 30: September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 98(3), 525-538 (2001)
18. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412-419 (1985) (Pubitemid 15018832)
19. B. Telejko, M. Kuzmicki, N. Wawrusiewicz-Kurylonek, J. Szamatowicz, A. Nikolajuk, A. Zonenberg, D. Zwierz-Gugala, W. Jelski, P. Laudanski, J. Wilczynski, A. Kretowski, M. Gorska, Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus. Diabet. Res. Clin. Pract. 87(2), 176-183 (2010). doi:10.1016/j.diabres.2009.10.018
20. L. Wei, X. Hou, K. Tatemoto, Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul. Pept. 132(1-3), 27-32 (2005). doi:10.1016/j.regpep.2005.08.003 (Pubitemid 41607499)
21. T. Van Mieghem, R. van Bree, E. Van Herck, R. Pijnenborg, J. Deprest, J. Verhaeghe, Maternal apelin physiology during rat pregnancy: the role of the placenta. Placenta 31(8), 725-730 (2010). doi:10.1016/j.placenta.2010.06.001
22. A. Kourtis, A. Gkiomisi, M. Mouzaki, K. Makedou, A.D. Anastasilakis, K.A. Toulis, S. Gerou, E. Gavana, T. Agorastos, Apelin levels in normal pregnancy. Clin. Endocrinol. (Oxf) 75(3), 367-371 (2011). doi:10.1111/j.1365-2265.2011. 04061.x
23. L. Cobellis, M. De Falco, A. Mastrogiacomo, D. Giraldi, D. Dattilo, C. Scaffa, N. Colacurci, A. De Luca, Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol. Histopathol. 22(1), 1-8 (2007) (Pubitemid 46117085)
24. T. Josephs, H. Waugh, I. Kokay, D. Grattan, M. Thompson, Fasting-induced adipose factor identified as a key adipokine that is up-regulated in white adipose tissue during pregnancy and lactation in the rat. J. Endocrinol. 194(2), 305-312 (2007). doi: 10.1677/JOE-07-0158 (Pubitemid 47249669)
25. R. Gonzalez, A. Tiwari, S. Unniappan, Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem. Biophys. Res. Commun. 381(4), 643-648 (2009). doi: 10.1016/j.bbrc.2009.02.104
26. K.S. Foo, H. Brauner, C.G. Ostenson, C. Broberger, Nucleobindin-2/ nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J. Endocrinol. 204(3), 255-263 (2010). doi:10.1677/JOE-09-0254
27. R. Gonzalez, B.K. Reingold, X. Gao, M.P. Gaidhu, R.G. Tsushima, S. Unniappan, Nesfatin-1 exerts a direct, glucosedependent insulinotropic action on mouse islet beta- and MIN6 cells. J. Endocrinol. 208(3), R9-R16 (2011). doi:10.1530/JOE-10-0492
28. Y. Su, J. Zhang, Y. Tang, F. Bi, J.N. Liu, The novel function of nesfatin-1: anti-hyperglycemia. Biochem. Biophys. Res. Commun. 391(1), 1039-1042 (2010). doi:10.1016/j.bbrc.2009.12.014
29. B.E. Metzger, S.G. Gabbe, B. Persson, T.A. Buchanan, P.A. Catalano, P. Damm, A.R. Dyer, A. Leiva, M. Hod, J.L. Kitzmiler, L.P. Lowe, H.D. McIntyre, J.J. Oats, Y. Omori, M.I. Schmidt, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabet. Care 33(3), 676-682 (2010). doi: 10.2337/dc09-1848